3449 results for «2025年12月15日嘉实上证科创板生物医药ETF（588700）最新净值»
3449 results
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
TAVI in 2025: transforming care with the new valvular heart disease guidelines
18 Nov 2025 – From PCR London Valves 2025
This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...
Most impactful trials in structural heart disease 2024/2025
30 Sep 2025 – From PCR Gulf Valves 2025
Delve into the most impactful structural heart disease trials shaping 2024 and 2025. This session addresses current dilemmas in TAVI, including early intervention and management of small annuli, evaluates evidence for transcatheter mitral and tricuspid valve repair, and identifies evidence gaps relevant to the region, providing...
How to deal with secondary mitral regurgitation in 2025?
20 May 2025 – From EuroPCR 2025
Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.
PCR Tokyo Valves 2025 Welcome Ceremony
08 Feb 2025 – From PCR Tokyo Valves 2025
Relive the 10th PCR Tokyo Valves Opening Ceremony, starting with a heartfelt tribute to Kentaro Hayashida and Shigeru Saito, the visionaries behind this enduring Course. Look back on a decade of growth, meet past directors, and hear inspiring testimonials from key contributors and participants. Finally, enjoy...
Best of AICT-AsiaPCR 2025
PCR Board 2025
09 Jan 2017
PCR is an organisation dedicated to education and information in the field of cardiovascular therapies, most notably for cardiovascular intervention and interventional medicine. Consult who the PCR Board members are ...
Coronary Interventions: EuroPCR 2025 highlights
22 May 2025 – From EuroPCR 2025
At EuroPCR 2025, Rasha Al-Lamee, Nieves Gonzalo, and Thomas Cuisset highlighted key advances in coronary interventions, with a strong emphasis on managing complex cases—particularly calcified lesions.
Throughout the Course, LIVE cases and expert hotlines showcased dedicated devices and evolving strategies designed specifically for these challenging lesions. Advanced...
PCRonline @ ESC Congress 2025: the interventional cardiology perspective!
26 Jul 2025
Stay updated with the latest in interventional cardiology at #ESCCongress 2025!
Simultaneous publications EuroPCR 2025
Digital coverage of #EuroPCR 2025
Best Clinical Cases of AICT-AsiaPCR 2025
10 Oct 2025 – From AICT-AsiaPCR 2025
This session showcases the best clinical cases from AICT-AsiaPCR 2025, highlighting complex scenarios such as post-trauma ST-elevations, transcatheter aortic valve implantation complexities, CTO-PCI in high-bleeding-risk patients, and challenging device retrievals. It emphasizes clinical decision-making and innovative interventional techniques in diverse cardiac pathologies.
Shaping the future: top innovations at PCR London Valves 2025
16 Nov 2025 – From PCR London Valves 2025
Highlighting transformative innovations from PCR London Valves 2025, this session features advanced technologies such as the Luna TMVR with its unique intuitive design, the novel Tripair technology for tricuspid therapy, and insights into right heart remodeling following transcatheter tricuspid valve interventions with the DUO system, showcasing...
GulfPCR-GIM 2025 - Course Programme
Ten trials from AHA 2025
12 Nov 2025
Alessandro Sticchi provides us with a curated overview of the late-breaking trials he found most relevant for interventional cardiologists from AHA 2025.
Author
EuroPCR 2025: Dive into the Scientific Programme!
What are the emerging indications for TAVI in 2025?
22 May 2025 – From EuroPCR 2025
Tiffany Patterson, Nicolas Van Mieghem, and Philippe Généreux discuss emerging indications for TAVI in 2025. They review recent evidence on asymptomatic severe aortic stenosis, highlighting four randomised trials—RECOVERY, AVATAR, ONLY TAVR, and EVoLVeD—that show TAVI or surgical AVR reduces hospitalisations for heart failure and trends toward...
EuroPCR 2025: Cutting through the complexity
20 May 2025
Complexity is the fil rouge of this year’s course but what does it mean to the Course Directors? And how can EuroPCR help participants cut through the complexity?
PCR @ TCT 2025 - Get the international perspective!
15 Oct 2025
Thanks to the contribution of a team of interventional cardiologists from around the globe, get the international perspective on Late-breaking Clinical Trials and Science released at TCT 2025 - check out the list below.
Dive into the #PCRimaging 2025 Course Programme!
